Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
4.150
-0.040 (-0.95%)
At close: Aug 7, 2025, 4:00 PM
4.148
-0.002 (-0.04%)
After-hours: Aug 7, 2025, 7:54 PM EDT
Nevro Market Cap
Atai Life Sciences has a market cap or net worth of $880.40 million as of August 7, 2025. Its market cap has increased by 234.97% in one year.
Market Cap
880.40M
Enterprise Value
811.16M
1-Year Change
234.97%
Ranking
Category
Stock Price
$4.15
Market Cap Chart
Since the IPO on June 18, 2021, Atai Life Sciences's market cap has decreased from $2.29B to $880.40M, a decrease of -61.53%. That is a compound annual growth rate of -20.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 880.40M | 294.48% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
| Jun 18, 2021 | 2.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 575.32B |
| Johnson & Johnson | 413.10B |
| AbbVie | 351.30B |
| Abbott Laboratories | 229.85B |
| AstraZeneca | 227.78B |
| Novartis AG | 223.01B |
| UnitedHealth Group | 221.95B |
| Novo Nordisk | 213.92B |